
Suboptimal care of peanut allergic children in Germany concerning professional dietary advice and the supply of self‐injectable epinephrine
Author(s) -
Trendelenburg V,
Blümchen K,
Ahrens F,
Gruebl A,
Hamelmann E,
Hansen G,
Heinzmann A,
Nemat K,
Niggemann B,
Beyer K
Publication year - 2013
Publication title -
clinical and translational allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.979
H-Index - 37
ISSN - 2045-7022
DOI - 10.1186/2045-7022-3-s3-p38
Subject(s) - medicine , peanut allergy , epinephrine , allergy , advice (programming) , family medicine , pediatrics , immunology , food allergy , computer science , programming language
Methods 63 peanut allergic children (median: age 6 years; peanutspecific IgE 73,5kU/l) who participated in an oral immunotherapy (OIT)-study were enrolled. Data concerning age of diagnosis, provision with self-injectable epinephrine, professional advice and performance of a peanut-free diet as well as the characterization of accidental allergic reactions to peanut (grade of severity I-V) were collected at their baseline visit of the OIT-study.